Jump to main content
Jump to site search

Issue 21, 2019
Previous Article Next Article

Hybridization chain reaction-based nanoprobe for cancer cell recognition and amplified photodynamic therapy

Author affiliations

Abstract

Precision diagnosis and effective treatment are the cores of early cancer therapy. Here, for the first time, we report a hybridization chain reaction-based nanoprobe for selective and sensitive cancer cell recognition and amplified photodynamic therapy.

Graphical abstract: Hybridization chain reaction-based nanoprobe for cancer cell recognition and amplified photodynamic therapy

Back to tab navigation

Supplementary files

Publication details

The article was received on 20 Dec 2018, accepted on 08 Feb 2019 and first published on 11 Feb 2019


Article type: Communication
DOI: 10.1039/C8CC10074H
Chem. Commun., 2019,55, 3065-3068

  •   Request permissions

    Hybridization chain reaction-based nanoprobe for cancer cell recognition and amplified photodynamic therapy

    M. Xiong, Q. Rong, G. Kong, C. Yang, Y. Zhao, F. Qu, X. Zhang and W. Tan, Chem. Commun., 2019, 55, 3065
    DOI: 10.1039/C8CC10074H

Search articles by author

Spotlight

Advertisements